|Articles|April 4, 2016
May 2016 — Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding
Author(s)DIA
Advertisement
Pharmaceutical compounding is an essential aspect of medicine in the US, although with inherent risks that must be understood and managed. In May 2016, the Special Section of
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
